Hesbaye Frost has enjoyed a particularly effective collaboration with Celabor laboratory for several years.
We particularly value the quality of the follow-up and the technical expertise provided for our analyses.
Your responsiveness in conducting tests, as well as the swift delivery of reports, are a major asset for our internal processes and enable us to ensure rigorous control of our products.
This reliability and availability daily reinforce the confidence we place in our partnership.

Nicolas Wladyka
Quality System Manager
Hesbaye Frost

Our long-standing collaboration has always been characterized by a high level of standards, rigor, and professionalism. Over the years, the consistent quality of our exchanges, the commitment, availability, and responsiveness of the Celabor staff, as well as the reliability of the results, have built a solid and lasting relationship of trust.
Jean-Marie Graff
Environmental Manager

At KitoZyme, we particularly value the close and constructive collaboration developed with Celabor. Their expertise in routine analyses, analytical development, and support for R&D projects is a real asset for our activities.
Within the framework of innovative projects such as the P³ project, a next-generation Production Platform assisted by Physical methods to sustainably valorize biomass into bio-based chitosan, funded by the Walloon Region, Celabor supports us by providing cutting-edge scientific expertise in extraction processes. Their thorough understanding of our R&D challenges and their solution-oriented approach enable us to explore, optimize, and secure new development pathways. This close and proactive collaboration is an essential lever for advancing our research projects efficiently and robustly.
Celabor is a preferred partner for KitoZyme, reliable and committed, with whom we build solid and sustainable solutions.

Véronique Maquet
R&D Director – KitoZyme

Samabriva Biomanufacturing is a company specializing in the industrial-scale production of high-value natural plant molecules (primarily active pharmaceutical ingredients such as alkaloids, terpenes, etc.). The company utilizes an innovative platform to produce these molecules in bioreactors, allowing for the relocation of active molecule production—80% of which is currently produced outside of Europe—while reducing the carbon footprint and controlling production costs.
Once produced and secreted into a suitable culture medium, these molecules must be purified. Our collaboration with Celabor, initiated several years ago, has allowed us to demonstrate the feasibility of purifying such molecules to achieve purities >95%, with virtually no loss of biological material (5%). These results were achieved thanks to close collaboration between the two teams and the professionalism of the Celabor team, who demonstrated great commitment to our development projects.

Marina Guillet
CEO Samabriva